Colgate-Palmolive to develop anti-cancer mouthwash

Discussion in 'Dental' started by Smilemaker100, Dec 9, 2005.

  1. Smilemaker100

    Smilemaker100 Membership Revoked
    Removed 10+ Year Member

    Joined:
    Feb 24, 2004
    Messages:
    893
    Likes Received:
    1
    Manhattan-based Colgate-Palmolive Co. and biotech firm Introgen Therapeutics Inc. signed an agreement to develop oral care products aimed at fighting mouth cancer.

    Colgate bought $20 million of Austin, Tex.-based Introgen’s shares and acquired the rights to any products developed by the two companies. Introgen uses gene therapy to create anti-cancer agents.

    Researchers will use Introgen’s tumor suppressors to create oral rinses, gels and other products to treat patients diagnosed with leukoplakia -- a pre-cancerous condition that can lead to oral cancer.


    http://www.medgadget.com/archives/2005/11/prevent_oral_ca_1.html
     
  2. BigRedDentist

    BigRedDentist Senior Member
    5+ Year Member

    Joined:
    Dec 8, 2005
    Messages:
    168
    Likes Received:
    4
    Status:
    Pre-Dental
    Good stuff. I wonder if they are using an antagonist of the PML binding domain. Anyone know the molecular basis?
     

Share This Page